Patient-tailored risk assessment of obstructive coronary artery disease using Rubidium-82 PET-based myocardial flow quantification with visual interpretation

J Nucl Cardiol. 2023 Oct;30(5):1890-1896. doi: 10.1007/s12350-023-03237-z. Epub 2023 Apr 19.

Abstract

Introduction: Our aim was to estimate the probability of obstructive CAD (oCAD) for an individual patient as a function of the myocardial flow reserve (MFR) measured with Rubidium-82 (Rb-82) PET in patients with a visually normal or abnormal scan.

Materials and methods: We included 1519 consecutive patients without a prior history of CAD referred for rest-stress Rb-82 PET/CT. All images were visually assessed by two experts and classified as normal or abnormal. We estimated the probability of oCAD for visually normal scans and scans with small (5%-10%) or larger defects (> 10%) as function of MFR. The primary endpoint was oCAD on invasive coronary angiography, when available.

Results: 1259 scans were classified as normal, 136 with a small defect and 136 with a larger defect. For the normal scans, the probability of oCAD increased exponentially from 1% to 10% when segmental MFR decreased from 2.1 to 1.3. For scans with small defects, the probability increased from 13% to 40% and for larger defects from 45% to > 70% when segmental MFR decreased from 2.1 to 0.7.

Conclusion: Patients with > 10% risk of oCAD can be distinguished from patients with < 10% risk based on visual PET interpretation only. However, there is a strong dependence of MFR on patient's individual risk of oCAD. Hence, combining both visual interpretation and MFR results in a better individual risk assessment which may impact treatment strategy.

Keywords: 82Rb; MBF; Myocardial blood flow; PET myocardial perfusion imaging; Segmental MFR.

MeSH terms

  • Coronary Artery Disease* / diagnostic imaging
  • Coronary Circulation
  • Fractional Flow Reserve, Myocardial*
  • Humans
  • Myocardial Perfusion Imaging* / methods
  • Positron Emission Tomography Computed Tomography
  • Positron-Emission Tomography / methods
  • Risk Assessment
  • Rubidium Radioisotopes

Substances

  • Rubidium-82
  • Rubidium Radioisotopes